Newsroom

The Protea Foundation is dedicated to closing the financial gap between what clients can afford for therapy and the true cost of effective treatment. Every dollar contributed goes directly to client care, prioritizing trauma-informed, evidence-based therapies that...

Statement by Protea Founder, Cristina Pearse: I am living proof that MDMA-Assisted Therapy (MDMA-AT) is safe, effective, life-changing, and even life-saving. By not approving MDMA-AT, the FDA is risking the lives of the 13 million+ Americans suffering from PTSD. ...

Ketamine Insights A Podcast about Psychedelic Medicine and New Depression Treatments Cristina Pearse is interviewed by Molly at Ketamine Insights about her experience and advocacy for MDMA-Assisted Therapy. Access the full podcast episode here on SPOTIFY. Access this...

Emory researchers studying psychedelic-assisted treatment for PTSD Atlanta university’s study comes as FDA evaluates treating disorder with MDMA, a psychedelic drug also known as ecstasy. Researchers at the Emory Brain Health Center are studying how MDMA — a...

BLOOMBERG: Illegal Ecstasy Takes Step Toward Becoming Legal Drug for PTSD Almost forty years after it was banned, it’s taking a big step toward becoming a licensed treatment for post traumatic stress disorder. Read the full article here. Excerpt: In 2014, MAPS founded...

During the FDA advisory committee hearing on June 4, 2024, our founder & CEO, Cristina Pearse, urged the committee to save lives by approving MDMA-Assisted Therapy. Here is the full link to The New York Times article. "Each day we postpone this therapy, I ask, at...

We can’t stop trauma; bad things happen and will continue to happen. War, accidents, and natural disasters…but also childhood rape and violence, neglect, poverty, addiction, and broken homes. Traumatizing events and circumstances surround us no matter who or where we...

35th Annual Boston International Trauma Conference Protea Foundation is joining Bessel van der Kolk and the Trauma Research Foundation from May 1st to 4th for the 35th Annual Boston International Trauma Conference. The Trauma Research Foundation has a legacy spanning...

Psychedelics are outperforming trauma researchers’ expectations. But why? A new study offers big clues about where psychedelics’ superpowers come from. By Sigal Samuel  Jan 29, 2024, 7:00am EST   Bessel van der Kolk, one of the world’s top trauma experts, was...

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial Results from the phase 3 placebo-controlled MAPP2 trial show that MDMA-assisted therapy reduces post-traumatic stress disorder (PTSD) symptoms and functional impairment...